Analytical Treatment Interruption (ATI) to Assess the Immune System's Ability to Control HIV in Participants Who Became HIV-infected During the HVTN 703/HPTN 081 AMP Study
Clinical trial NCT04860323 · COMPLETED
Trial details
- NCT number
- NCT04860323
- Sponsor
- HIV Vaccine Trials Network
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-28
- Primary completion
- 2025-02-04
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.